Table 3.
Thoracic clinical toxicity adverse events for trial cohort*
| Patients, no. (%) | ||||
|---|---|---|---|---|
|
|
||||
| Adverse event | Grade 0 | Grade 1 | Grade 2 | Grade 3 |
| Pneumonitis | 42 (62.7) | 15 (22.4) | 7 (10.4) | 3 (4.5) |
| Esophagitis | 7 (10.4) | 27 (40.3) | 28 (41.8) | 5 (7.5) |
| Dyspnea | 15 (22.4) | 38 (56.7) | 10 (14.9) | 4 (6.0) |
| Cough | 7 (10.4) | 47 (70.1) | 13 (19.4) | 0 (0.0) |
| Fatigue | 5 (7.5) | 48 (71.6) | 12 (17.9) | 2 (3.0) |
The number and percentage of patients are reported for each adverse event and toxicity grade. The data are given for each particular grade of event rather than the number of events with a given grade or higher.